Bacainn Therapeutics is Drug Discovery in United States that focus on developer business. Founded in 2017. They cover business area such as developer, novel cell therapy, uncontrolled inflammation, dysregulate immune cell, development, novel immune cell-modulate drug, ulcerative colitis, diabetic wound healing, respiratory inflammation, oncology, medical professional, these drug, damaging inflammation.
2017
( 7 years old in 2024 )
Developer
-
530 Virginia Road
Suite 300
Concord, MA 01742
United States
Private
developernovel cell therapyuncontrolled inflammationdysregulate immune celldevelopmentnovel immune cell-modulate drugulcerative colitisdiabetic wound healingrespiratory inflammationoncologymedical professionalthese drugdamaging inflammation
* We use standard office opening hours in near Bacainn Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Bacainn Therapeutics is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), Bacainn Therapeutics business is focusing on Developer.
Bacainn Therapeutics headquarter office and corporate office address is located in 530 Virginia Road Suite 300 Concord, MA 01742 United States.
Bacainn Therapeutics was founded in United States.
In 2024, Bacainn Therapeutics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Bacainn Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
